Detalhe da pesquisa
1.
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study.
Br J Haematol
; 199(1): 54-60, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906881
2.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854643
3.
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
Cancer
; 127(18): 3413-3421, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181755
4.
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
Br J Haematol
; 195(3): 371-377, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272724
5.
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA).
Haematologica
; 103(9): 1422-1432, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049825
6.
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients.
Am J Hematol
; 97(8): E321-E324, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702859
7.
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Ann Hematol
; 99(8): 1951-1952, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529284
8.
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.
Blood Adv
; 6(1): 327-338, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644385
9.
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients.
Front Cardiovasc Med
; 8: 645678, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33969010
10.
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cancers (Basel)
; 13(7)2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915804
11.
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Lancet Haematol
; 7(10): e737-e745, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798473
12.
Efficacy of Tixagevimab-Cilgavimab as Immunoprophylaxis in Patients With Hematologic Cancer.
JAMA Oncol
; 10(3): 405-407, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270961
13.
Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy.
Cancers (Basel)
; 11(5)2019 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31058856
14.
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma.
Expert Opin Drug Metab Toxicol
; 14(1): 91-99, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29235380
15.
Determining treatment intensity in elderly patients with multiple myeloma.
Expert Rev Anticancer Ther
; 18(9): 917-930, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972740
16.
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma.
Expert Rev Anticancer Ther
; 17(1): 75-87, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27894203
17.
Melphalan hydrochloride for the treatment of multiple myeloma.
Expert Opin Pharmacother
; 18(11): 1127-1136, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28658983
18.
Novel investigational drugs active as single agents in multiple myeloma.
Expert Opin Investig Drugs
; 26(6): 699-711, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28448171
19.
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation.
Bone Marrow Transplant
; 57(1): 137-139, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635796
20.
Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins.
Leuk Lymphoma
; 57(3): 537-56, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26445358